PharmaCyte Biotech Inc Stock price
Is PharmaCyte Biotech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?
As a Free StocksGuide user, you can view scores for all 9,127 stocks worldwide.
Key metrics
PharmaCyte Biotech Inc Stock Analysis
Analyst Opinions
6 Analysts have issued a PharmaCyte Biotech Inc forecast:
Analyst Opinions
6 Analysts have issued a PharmaCyte Biotech Inc forecast:
Don't miss a Thing! We will send you all news about PharmaCyte Biotech Inc directly to your mailbox free of charge.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Company Profile
PharmaCyte Biotech, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of treatments for cancer and diabetes. It focuses on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box, which will be used as a platform for the development of treatments for inoperable pancreatic cancer and other solid cancerous tumors, and diabetes. The company was founded on October 28, 1996 and is headquartered in Laguna Hills, CA.
| Head office | United States |
| CEO | Mr. Silverman |
| Employees | 2 |
| Founded | 1996 |
| Website | pharmacyte.com |


